Navigation path

Gene Therapy

back home
Print version Increase text Decrease text

AAVEYE - Gene therapy for inherited severe photoreceptor diseases

ATTACK - Adoptive engineered T cell Trials to Achieve Cancer Killing

BRAINCAV - A European Consortium aiming at generating new tools to understand and treat brain diseases

CELL-PID - Advanced Cell-based Therapies for the treatment of Primary ImmunoDeficiency

EVERREST - Does vascular endothelial growth factor gene therapy safely improve outcome in severe early-onset fetal growth restriction?

NEUGENE - Advanced gene therapy tools for treatment of CNS-specific disorders

PERSIST - Persisting transgenesis

SKIP-NMD - A phase I/IIa clinical trial in Duchenne muscular dystrophy using systemically delivered morpholino antisense oligomer to skip exon 53

SUPERSIST - Towards clinical translation of new gene targeting technologies for correcting inherited mutations and empowering adoptive immunotherapy of cancer

TARGETAMD - Transposon-based, targeted ex vivo gene therapy to treat age-related macular degeneration (AMD)

T-CONTROL - Donor T Cells for Immune Control